1,396
Views
27
CrossRef citations to date
0
Altmetric
Reviews

Occurrence, biological properties and potential effects on human health of β-casomorphin 7: Current knowledge and concerns

, , ORCID Icon, ORCID Icon & ORCID Icon

References

  • Abriel, H., and E.V. Zaklyazminskaya. 2013. Cardiac channelopathies: Genetic and molecular mechanisms. Gene 517 (1):1–11. doi: 10.1016/j.gene.2012.12.061.
  • Anderson, O.S., K.E. Sant, and D.C. Dolinoy. 2012. Nutrition and epigenetics: An interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. The Journal of Nutritional Biochemistry 23 (8):853–9. doi: 10.1016/j.jnutbio.2012.03.003.
  • Arisoy, S., and Ö. Ustun-Aytekin. 2018. Hydrolysis of food-derived opioids by dipeptidyl peptidase IV from Lactococcus lactis spp. lactis. Food Research International 111:574–81.
  • Asledottir, T., T.T. Le, T.T. Thu, B. Petrat-Melin, T.G. Devold, L.B. Larsen, and G.E. Vegarud. 2017. Identification of bioactive peptides and quantification of β-casomorphin-7 from bovine β-casein A1, A2 and I after ex vivo gastrointestinal digestion. International Dairy Journal 71:98–106. doi: 10.1016/j.idairyj.2017.03.008.
  • Asledottir, T., T.T. Le, N. A. Poulsen, T.G. Lotte, B. Larsen, and G.E. Vegarud. 2018. Release of β-casomorphin-7 from bovine milk of different β-casein variants after ex vivo gastrointestinal digestion. International Dairy Journal 81:8–11. doi: 10.1016/j.idairyj.2017.12.014.
  • Asledottir, T., G. Picariello, G. Mamone, P. Ferranti, A. Roseth, T.G. Devold, and G.E. Vegarud. 2019. Degradation of beta-casomorphin-7 through in vitro gastrointestinal and jejunal brush border membrane digestion. Journal of Dairy Science 102 (10):8622–9. doi: 10.3168/jds.2019-16771.
  • Banks, W. A., and A. J. Kastin. 1987. Saturable transport of peptides across the blood-brain barrier. Life Sciences 41 (11):1319–38. doi: 10.1016/0024-3205(87)90606-0.
  • Barnett, M.P.G., W.C. McNabb, N.C. Roy, K.B. Woodford, and A.J. Clarke. 2014. Dietary A1 β-casein affects gastrointestinal transit time, dipeptidyl peptidase-4 activity, and inflammatory status relative to A2 β-casein in Wistar rats. International Journal of Food Sciences and Nutrition 65 (6):720–7. doi: 10.3109/09637486.2014.898260.
  • Bartley, J., and S.R. McGlashan. 2010. Does milk increase mucus production? Medical Hypotheses 74 (4):732–4. doi: 10.1016/j.mehy.2009.10.044.
  • Bashir, S., and L. Al-Ayadhi. 2014. Alterations in plasma dipeptidyl peptidase IV in autism: A pilot study. Neurology, Psychiatry and Brain Research 20 (2):41–4. doi: 10.1016/j.npbr.2014.03.001.
  • Beales, P., R. Elliott, S. Flohé, J. Hill, H. Kolb, P. Pozzilli, G.S. Wang, H. Wasmuth, and F. Scott. 2002. A multi-center, blinded international trial of the effect of A 1 and A 2 ß-casein variants on diabetes incidence in two rodent models of spontaneous. Type I diabetes. Diabetologia 45 (9):1240–6. doi: 10.1007/s00125-002-0898-2.
  • Boro, P., B.C. Naha, D.P. Saikia, and C. Prakash. 2016. A1 and A2 milk and its impact on human health. International Journal of Science and Nature 7:1–5.
  • Boutrou, R., C. Gaudichon, D. Dupont, J. Jardin, G. Airinei, A. Marsset-Baglieri, R. Benamouzig, D. Tomé, and J. Leonil. 2013. Sequential release of milk protein-derived bioactive peptides in the jejunum in healthy humans. The American Journal of Clinical Nutrition 97 (6):1314–23. doi: 10.3945/ajcn.112.055202.
  • Boutrou, R., G. Henry, and L. Sanchez-Rivera. 2015. On the trail of milk bioactive peptides in human and animal intestinal tracts during digestion: A review. Dairy Science & Technology 95:815–29. doi: 10.1007/s13594-015-0210-0.
  • Brantl, V., H. Teschemacher, A. Henschen, and F. Lottspeich. 1979. Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone. Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie 360 (2):1211–6. doi: 10.1515/bchm2.1979.360.2.1211.
  • Brantl, V., H. Teschemacher, J. Bläsig, A. Henschen, and F. Lottspeich. 1981. Opioid activities of β-casomorphins. Life Sciences 28:1903–09.
  • Brion, M., C. Allegue, M. Santori, R. Gil, A. Blanco-Verea, C. Haas, C. Bartsch, S. Poster, B. Madea, O. Campuzano, et al. 2012. Sarcomeric gene mutations in sudden infant death syndrome (SIDS). Forensic Science International 219 (1–3):278–81. doi: 10.1016/j.forsciint.2012.01.018.
  • Brooke-Taylor, S., K. Dwyer, K. Woodford, and N. Kost. 2017. Systematic review of the gastrointestinal effects of A1 compared with A2 β-Casein. Advances in Nutrition: An International Review Journal 15:739–48. doi: 10.3945/an.116.013953.
  • Cade, R., M. Privette, M. Fregly, N. Rowland, Z. Sun, V. Zele, H. Wagemaker, and C. Edelstein. 2000. Autism and schizophrenia: Intestinal disorders. Nutritional Neuroscience 3 (1):57–72. doi: 10.1080/1028415X.2000.11747303.
  • Carlin, R.F., and R.Y. Moon. 2017. Risk factors, protective factors, and current recommendations to reduce sudden infant death syndrome: A review. JAMA Pediatrics 171 (2):175–80. doi: 10.1001/jamapediatrics.2016.3345.
  • Campuzano, O., C. Allegue, G. Sarquella-Brugada, M. Coll, J. Mates, M. Alcalde, C. Ferrer-Costa, A. Iglesias, J. Brugada, and R. Brugada. 2014. The role of clinical, genetic and segregation evaluation in sudden infant death. Forensic Science International 242:9–15. doi: 10.1016/j.forsciint.2014.06.007.
  • Cattaneo, S., M. Stuknytė, F. Masotti, and I. D. Noni. 2017. Protein breakdown and release of β-casomorphins during in vitro gastro-intestinal digestion of sterilised model systems of liquid infant formula. Food Chemistry 217:476–82. doi: 10.1016/j.foodchem.2016.08.128.
  • Chia, J.S.J., J.L. McRae, S. Kukuljian, K. Woodford, R.B. Elliott, B. Swinburn, and K.M. Dwyer. 2017. A1 β-casein milk protein and other environmental pre-disposing factors for type 1 diabetes. Nutrition & Diabetes 7:e274. doi: 10.1038/nutd.2017.16.
  • Choi, J., L. Sabikhi, A. Hassan, and S. Anand. 2012. Bioactive peptide in dairy products. International Journal of Dairy Technology 65 (1):1–12. doi: 10.1111/j.1471-0307.2011.00725.x.
  • Cieślińska, A., E. Kostyra, H. Kostyra, K. Oleński, E. Fiedorowicz, and S. Kamiński. 2012. Milk from cows of different β-casein genotypes as a source of β-casomorphin-7. International Journal of Food Sciences and Nutrition 63 (4):426–30. doi: 10.3109/09637486.2011.634785.
  • Cieślińska, A., E. Sienkiewicz-Szłapka, J. Wasilewska, E. Fiedorowicz, B. Chwała, M. Moszyńska-Dumara, T. Cieśliński, M. Bukało, and E. Kostyra. 2015. Influence of candidate polymorphisms on the dipeptidyl peptidase IV and μ-opioid receptor genes expression in aspect of the β-casomorphin-7 modulation functions in autism. Peptides 65:6–11. doi: 10.1016/j.peptides.2014.11.012.
  • Cieślińska, A., E. Kostyra, and H.F.J. Savelkoul. 2017. Treating autism spectrum disorder with gluten-free and casein-free diet: The underlying microbiota-gut-brain axis mechanisms. Journal of Clinical Immunology and Immunotheraphy 3:9.
  • Clare, D.A., and H. Swaisgood. 2000. Invited review bioactive milk peptides: A prospectus. Journal of Dairy Science 86:1187–95. doi: 10.3168/jds.S0022-0302(00)74983-6.
  • Clemens, R.A., O. Hemell, and K.F. Michaelsen. 2011. Milk A1 and A2 peptides and diabetes. Nestle Nutrition Workshop Series. Paediatric Programme 67:187–95. doi: 10.1159/000325584.
  • Crowley, E.T., L.T. Williams, T.K. Roberts, R.H. Dunstan, and P.D. Jones. 2013. Does milk cause constipation? A crossover dietary trial. Nutrients 5 (1):253–66. doi: 10.3390/nu5010253.
  • Dahan, A., L. Aarts, and T.W. Smith. 2010. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology 112 (1):226–38. doi: 10.1097/ALN.0b013e3181c38c25.
  • Dalziel, J.E., N.J. Spencer, K.E. Dunstan, A.T. Lynch, N.W. Haggarty, P.K. Gopal, and N.C. Roy. 2014. An in vitro rat model of colonic motility to determine the effect of beta-casomorphin-5 on propagating contractions. Food and Function 5 (11):2768–74. doi: 10.1039/C4FO00193A.
  • Davis, T. P., T. J. Abbruscato, and R. D. Egleton. 2015. Peptides at the blood brain barrier: Knowing me knowing you. Peptides 72:50–6. doi: 10.1016/j.peptides.2015.04.020.
  • De Magistris, L., V. Familiari, A. Pascotto, A. Sapone, A. Frolli, P. Iardino, M. Carteni, M. De Rosa, R. Francavilla, G. Riegler, et al. 2010. Alterations of the intestinal barrier in patients with autism spectrum disorders and the first-degree relatives. Journal of Pediatric Gastroenterology and Nutrition 51 (4):418–24. doi: 10.1097/MPG.0b013e3181dcc4a5.
  • De Noni, I. 2008. Release β-casomorphins 5 and 7 during Simulated Gastro Intestinal Digestion of bovine β-Casein variants and milk-based infant formulas. Food Chemistry 110 (4):897–903. doi: 10.1016/j.foodchem.2008.02.077.
  • De Noni, I., and S. Cattaneo. 2010. Occurrence of β-casomorphins 5 and 7 in commercial dairy products and in their digests following in vitro simulated gastro-intestinal digestion. Food Chemistry 119 (2):560–6. doi: 10.1016/j.foodchem.2009.06.058.
  • De Noni, I., M. Stuknytė, and S. Cattaneo. 2015. Identification of β-casomorphins 3 to 7 in cheeses and in their in vitro gastrointestinal digestates. Lwt—Food Science and Technology 63 (1):550–5. doi: 10.1016/j.lwt.2015.03.036.
  • DeHaven-Hudkins, D.L., R.N. DeHaven, P.J. Little, and L.M. Techner. 2008. The involvement of the µ-opioid receptor in gastrointestinal pathophysiology: Therapeutic opportunities for antagonism at this receptor. Pharmacology & Therapeutics 117:162–87. doi: 10.1016/j.pharmthera.2007.09.007.
  • Deth, R., A. Clarke, J. Ni, and M. Trivedi. 2016. Clinical evaluation of glutathione concentrations after consumption of milk containing different subtypes of β-casein: Results from a randomized, cross-over clinical trial. Nutrition Journal 15 (1):82. doi: 10.1186/s12937-016-0201-x.
  • Dettmer, K., D. Hanna, P. Whetstone, R. Hansen, and B.D. Hammock. 2007. Autism and urinary exogenous neuropeptides: Development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory. Analytical and Bioanalytical Chemistry 388 (8):1643–51. doi: 10.1007/s00216-007-1301-4.
  • Donkor, O.N., A. Henriksson, T.K. Singh, T. Vasiljevic, and N.P. Shah. 2007. ACE-Inibitory activity of probiotic yogurt. International Dairy Journal 17 (11):1321–31. doi: 10.1016/j.idairyj.2007.02.009.
  • Duarte-Vázquez, M.Á., C. García-Ugalde, L.M. Villegas-Gutiérrez, B.E. García-Almendárez, and J.L. Rosado. 2017. Production of cow’s milk free from beta-casein A1 and its application in the manufacturing of specialized foods for early infant nutrition. Foods 6 (7):50. doi: 10.3390/foods6070050.
  • Duraffourd, C., F. De Vadder, D. Goncalves, F. Delaere, A. Penhoat, B. Brusset, F. Rajas, D. Chassard, A. Duchampt, A. Stefanutti, et al. 2012. Mu-opioid receptors and dietary protein stimulate a gut-brain neural circuitry limiting food intake. Cell 150 (2):377–88. doi: 10.1016/j.cell.2012.05.039.
  • EFSA (European Food Safety Authority). 2009. Review of the potential health impact of β-casomorphins and related peptides. EFSA Scientific Report 231:1–107.
  • Elder, J.H., C. Maun Kreider, N.M. Schaefer, and M.B. de Laosa. 2015. A review of gluten- and casein-free diets for treatment of autism: 2005-2015. Nutrition and Dietary Supplements 7:87–101. doi: 10.2147/NDS.S74718.
  • Elliott, R.B., H.E. Wasmuth, N.J. Bibby, and J.P. Hill. 1997. The role of β-casein in the induction of insulin-dependent diabetes in the non-obese diabetic mouse and humans. In Proc. IDF Seminar, 445–453. Palmerston North, NZ.
  • Elliott, R.B., D.P. Harris, J.P. Hill, N.J. Bibby, and H.E. Wasmuth. 1999. Type I (Insulin-dependent) diabetes mellitus and cow milk: Casein variant consumption. Diabetologia 42 (3):292–6. doi: 10.1007/s001250051153.
  • Farrell, H.M., R. Jimenez-Flores, G.T. Bleck, E.M. Brown, J.E. Butler, L.K. Creamer, C.L. Hicks, C.M. Hollar, K.F. Ng-Kwai-Hang, and H.E. Swaisgood. 2004. Nomenclature of the proteins of cow’s milk—sixth revision. Journal of Dairy Science 87 (6):1641–74. doi: 10.3168/jds.S0022-0302(04)73319-6.
  • Fiedorowicz, E., B. Jarmołowska, M. Iwan, E. Kostyra, R. Obuchowicz, and M. Obuchowicz. 2011. The influence of μ-opioid receptor antgonist peptides on peripheral blood mononuclear cells (PBMCs). Peptides 32 (4):707–12. doi: 10.1016/j.peptides.2010.12.003.
  • Fiedorowicz, E., M. Kaczmarski, A. Cieślińska, E. Sienkiewicz-Szłapka, B. Jarmołowska, B. Chwała, and E. Kostyra. 2014. β-casomorphin-7 alters μ-opioid receptor and dipeptidyl peptidase IV genes expression in children with atopic dermatitis. Peptides 62:144–9. doi: 10.1016/j.peptides.2014.09.020.
  • Fiedorowicz, E., L.H. Markiewicz, K. Sidor, D. Świątecka, A. Cieślińska, M. Matysiewicz, K. Piskorz-Ogórek, E. Sienkiewicz-Szłapka, M. Teodorowicz, A. Świątecki, et al. 2016. The influence of breast milk and infant formulae hydrolysates on bacterial adhesion and caco-2 cells functioning. Food Research International 89:679–88. doi: 10.1016/j.foodres.2016.09.022.
  • FitzGerald, R.J., and H. Meisel. 2000. Milk protein-derived peptide inhibitors of Angiotensin-I-converting enzyme. British Journal of Nutrition 84 (S1):33–7. doi: 10.1017/S0007114500002221.
  • Formaggioni, P., A. Summer, M. Malacarne, and P. Mariani. 1999. Milk protein polymorphism: Detection and diffusion of the genetic variants in Bos genus. Ann. Fac. Med. Vet. Univ. Parma 19:127–65.
  • Garland, E.L. 2012. Pain processing in the human nervous system: A selective review of nociceptive and biobehavioral pathways. Primary Care: Clinics in Office Practice 39:561–71. doi: 10.1016/j.pop.2012.06.013.
  • Gaudry, D. K. d., S. Lohner, C. Schmucker, P. Kapp, E. Motschall, S. Horrlein, C. Roger, and J. J. Meerpohl. 2019. Milk A1 beta-casein and health-related outcomes in humans: A systematic review. Nutrition Reviews 77:278–306. doi: 10.1093/nutrit/nuy063.
  • Giromini, C., F. Cheli, R. Rebucci, and A. Baldi. 2019. Invited review: Dairy proteins and bioactive peptides: Modeling digestion and the intestinal barrier. Journal of Dairy Science 102 (2):929–42. doi: 10.3168/jds.2018-15163.
  • Gustavsson, F., A.J. Buitenhuis, M. Glantz, H. Stalhammar, H. Lindmark-Mansson, N.A. Poulsen, L.B. Larsen, A. Andren, and M. Paulsson. 2014. Impact of genetic variants of milk proteins on chymosin-induced gelation properties of milk from individual cows of Swedish red dairy cattle. International Dairy Journal 39 (1):102–7. doi: 10.1016/j.idairyj.2014.05.007.
  • Hafeez, Z., C. Cakir-Kiefer, J.M. Girardet, J. Jardin, C. Perrin, A. Dary, and L. Miclo. 2013. Hydrolysis of milk-derived bioactive peptides by cell-associated extracellular peptidases of Streptococcus thermophilus. Applied Microbiology and Biotechnology 97 (22):9787–99. doi: 10.1007/s00253-013-5245-7.
  • Hafeez, Z., C. Cakir-Kiefer, X. Lecomte, L. Miclo, and A. Dary-Mourot. 2019. The X-prolyl dipeptidyl-peptidase PepX of Streptococcus thermophilus initially described as intracellular is also responsible for peptidase extracellular activity. Journal of Dairy Science 102 (1):113–23. doi: 10.3168/jds.2018-14823.
  • Han, D.N., D.H. Zhang, L.P. Wang, and Y.S. Zhang. 2013. Protective effect of β-casomorphin-7 on cardiomyopathy of streptozotocin-induced diabetic rats via inhibition of hyperglycemia and oxidative stress. Peptides 44:120–6. doi: 10.1016/j.peptides.2013.03.028.
  • Hannah, C., M.D. Kinney, and T.T. Bradley. 2009. The sudden infant death syndrome. New England Journal of Medicine 361:795–805. doi: 10.1056/NEJMra0803836.
  • Harjustalo, V., L. Sjoberg, and J. Tuomilehto. 2008. The trending the incidence of type 1 diabetes in Finnish children: A cohort study. The Lancet 371:1777–82. doi: 10.1016/S0140-6736(08)60765-5.
  • Hartmann, R., and H. Meisel. 2007. Food-derived peptides with biological activity: From research to food applications. Current Opinion in Biotechnology 18 (2):163–9. doi: 10.1016/j.copbio.2007.01.013.
  • He, M., S. Jianqin, J. Qin, and Y. Xin. 2017. Effects of cow’s milk beta-casein variants on symptoms of milk intolerance in Chinese. Nutrition Journal 16 (1):72. doi: 10.1186/s12937-017-0275-0.
  • Henschen, A., F. Lottspeich, V. Brantl, and H. Teschemacher. 1979. Novel opioid peptides derived from casein (beta-casomorphins). II. Structure of active components from bovine casein peptone. Hoppe-Seyler's Zeitschrift Fur Physiologische Chemie 360 (9):1217–24.
  • Hidalgo, I.J., T.J. Raub, and R.T. Borchardt. 1989. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96 (2):736–49. doi: 10.1016/0016-5085(89)90897-4.
  • Ho, S., K. Woodford, S. Kukuljan, and S. Pal. 2014. Comparative effects of A1 versus A2 β-casein on gastrointestinal measures: A blinded randomised cross-over pilot study. European Journal of Clinical Nutrition 68 (9):994–1000. doi: 10.1038/ejcn.2014.127.
  • Holt, C., J.A. Carver, H. Ecroyd, and D.C. Thorn. 2013. Invited review: Caseins and the casein micelle: Their biological functions, structures, and behavior in foods. Journal of Dairy Science 96 (10):6127–46. doi: 10.3168/jds.2013-6831.
  • Hunter, L. C., A. O'Hare, W. J. Herron, L. A. Fisher, and G. E. Jones. 2003. Opioid peptides and dipeptidyl peptidase in autism. Developmental Medicine & Child Neurology 45 (2):121–8. doi: 10.1111/j.1469-8749.2003.tb00915.x.
  • Huppertz, T. 2013. Chemistry of caseins. In Advanced dairy chemistry (Volume 1A), ed. P.L.H McSweeney and P.F. Fox, 135–60. 4th ed. Boston: Springer Science.
  • Ilonen, J., A. Hammais, A.P. Laine, J. Lempainen, O. Vaarala, R. Veijola, O. Simell, and M. Knip. 2013. Patterns of β-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 62 (10):3636–40. doi: 10.2337/db13-0300.
  • Iwan, M., B. Jarmolowska, K. Bielikowicz, E. Kostyra, H. Kostyra, and M. Kaczmarski. 2008. Transport of μ-opioid receptor agonist and antagonist peptides across Caco-2 monolayer. Peptides 6:1042–7. doi: 10.1016/j.peptides.2008.01.018.
  • Jarmolowska, B., M. Teodorowicz, E. Fiedorowicz, E. Sienkiewicz-Szlapka, M. Matysiewicz, and E. Kostyra. 2013. Glucose and calcium ions may modulate the efficiency of bovine beta-casomorphin-7 permeability through a monolayer of Caco-2 cells. Peptides 49:59–67. doi: 10.1016/j.peptides.2013.08.017.
  • Jarmolowska, B., M. Bukało, E. Fiedorowicz, A. Cieślińska, N.K. Kordulewska, M. Moszyńska, A. Świątecki, and E. Kostyra. 2019. Role of milk-derived opioid peptides and proline dipeptidyl peptidase-4 in autism spectrum disorders. Nutrients 11:2–13. doi: 10.3390/nu11010087.
  • JianQin, S., X. LeiMing, X. Lu, G.W. Yelland, N. JiaYi, and A.J. Clarke. 2016. Effects of milk containing only A2 beta casein versus milk containing both A1 and A2 beta casein proteins on gastrointestinal physiology, symptoms of discomfort, and cognitive behavior of people with self-reported intolerance to traditional cows’ milk. Nutrition Journal 15 (1):35. doi: 10.1186/s12937-016-0147-z.
  • Jinsmaa, Y., and M. Yoshikawa. 1999. Enzymatic release of neocasomorphin and β-casomorphin from β-casein. Peptides 20 (8):957–62. doi: 10.1016/S0196-9781(99)00088-1.
  • Kaminski, S., A. Cieślińska, and E. Kostyra. 2007. Polymorphism of bovine β-casein and its potential effect on human health. Journal of Applied Genetics 48:189–98. doi: 10.1007/BF03195213.
  • Kastin, A. J., W.A. Banks, and J.E. Zadina. 1990. A decade of changing perceptions about neuropetides. Annals of the New York Academy of Sciences 579 (1 A Decade of N):1–7. doi: 10.1111/j.1749-6632.1990.tb48348.x.
  • Ketto, I.A., T.M. Knutsen, J. Øyaas, B. Heringstad, T. Ådnøy, T.G. Devold, and S.B. Skeie. 2017. Effects of milk protein polymorphism and composition, casein micelle size and salt distribution on the milk coagulation properties in Norwegian red cattle. International Dairy Journal 70:55–64. doi: 10.1016/j.idairyj.2016.10.010.
  • Kiefer-Partsch, B., W. Bockelmann, A. Geis, and M. Teuber. 1989. Purification of an X-prolyl-dipeptidyl aminopeptidase from the cell wall proteolytic system of Lactococcus lactis subsp. cremoris. Applied Microbiology and Biotechnology 31 (1):75–8. doi: 10.1007/BF00252531.
  • Kiela, P. R., and F. K. Ghishan. 2016. Physiology of intestinal absorption and secretion. Best Practice & Research Clinical Gastroenterology 30:145–59. doi: 10.1016/j.bpg.2016.02.007.
  • Knip, M., S. M. Virtanen, and H. K. Åkerblom. 2010. Infant feeding and risk of type I diabetes. The American Journal of Clinical Nutrition 91 (5):1506S–13S. doi: 10.3945/ajcn.2010.28701C.
  • Knip, M., and O. Simell. 2012. Environmental triggers of type I diabetes. Cold Spring Harbor Perspectives in Medicine 2:a007690. doi: 10.1101/cshperspect.a007690.
  • Koch, G., K. Wiedemann, and H. Teschemacher. 1985. Opioid activities of human beta-casomorphins. Naunyn-Schmiedeberg's Archives of Pharmacology 331 (4):351–4. doi: 10.1007/BF00500818.
  • Korhonen, H., and A. Pihlanto. 2006. Review bioactive peptides: Production and functionally. International Dairy Journal 16 (9):945–60. doi: 10.1016/j.idairyj.2005.10.012.
  • Kost, N.V., O.Y. Sokolov, O.B. Kurasova, A.D. Dmitriev, J.N. Tarakanova, M.V. Gabaeva, Y.A. Zolotarev, A.K. Dadayan, S.A. Grachev, E.V. Korneeva, et al. 2009. β-Casomorphins-7 in infants on different type of feeding and different levels of psychomotor development. Peptides 30 (10):1854–60. doi: 10.1016/j.peptides.2009.06.025.
  • Kostyra, E., E. Sienkiewicz-Szłpka, B. Jarmolowska, S. Krawczuck, and H. Kostyra. 2004. Opioid peptides derived from milk proteins. Pul. J. Food Nutr. Sci 54 (special issue 1S):25–35.
  • Krischer, J.P., K.F. Lynch, D.A. Schatz, J. Ilonen, A. Lernmark, W. A. Hagopian, M. J. Rewers, J. X. She, O. G. Simell, J. Toppari, et al. 2015. The 6-year incidence of diabetes-associated autoantibodies in genetically at-risk children: The TEDDY study. Diabetologia 58 (5):980–7. doi: 10.1007/s00125-015-3514-y.
  • Laër, K., T. Dürk, M. Vennemann, T. Rothämel, and M. Klintshar. 2015. Polymorphism in genes of respiratory control and sudden infant death syndrome. International Journal of Legal Medicine 129:977–84. doi: 10.1007/s00414-015-1232-0.
  • Lange, K.W., J. Hauser, and A. Reissmann. 2015. Gluten-free and casein-free diets in the therapy of autism. Current Opinion in Clinical Nutrition and Metabolic Care 18 (6):572–5. doi: 10.1097/MCO.0000000000000228.
  • Laugesen, M., and R. Elliott. 2003. Ischaemic heart disease, type 1 diabetes, and cow milk A1 β-casein. New Zealand Medical Journal 116:11–68.
  • Lázaro, C.P., M.P. Pondé, and L.E. Rodrigues. 2016. Opioid peptides and gastrointestinal symptoms in autism spectrum disorders. Revista Brasileira de Psiquiatria 38 (3):243–6. doi: 10.1590/1516-4446-2015-1777.
  • Le Merrer, J., J.A. Becker, K. Befort, and B.L. Kieffer. 2009. Reward processing by the opioid system in the brain. Physiological Reviews 89 (4):1379–412. doi: 10.1152/physrev.00005.2009.
  • Linnebank, M., J. Popp, Y. Smulders, D. Smith, A. Semmler, M. Farkas, L. Kulic, G. Cvetanovska, H. Blom, B. Stoffel-Wagner, et al. 2010. S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer’s disease. Neurodegenerative Diseases 7 (6):373–8. doi: 10.1159/000309657.
  • Lubel, J.S., C.B. Herath, L.M. Burrell, and P. Angus. 2008. Liver disease and the renin-angiotensin system: Recent discoveries and clinical implications. Journal of Gastroenterology and Hepatology 23 (9):1327–38. doi: 10.1111/j.1440-1746.2008.05461.x.
  • Luopajärvi, K., E. Savilahti, S.M. Virtanen, J. Ilonen, M. Knip, H.K. Akerblom, and K. Vaarala. 2008. Enhanced levels of cow’s milk antibodies in infancy in children who develop type 1 diabetes later in childhood. Pediatric Diabetes 9 (5):434–41. doi: 10.1111/j.1399-5448.2008.00413.x.
  • Mankertz, J., and J.D. Schulzke. 2007. Altered permeability in inflammatory bowel disease: Pathophysiology and clinical implications. Current Opinion in Gastroenterology 23 (4):379–83. doi: 10.1097/MOG.0b013e32816aa392.
  • Martínez-Maqueda, D., B. Miralles, S. De Pascual-Teresa, I. Reverón, R. Muñoz, and I. Recio. 2012. Food-derived peptides stimulate mucin secretion and gene expression in intestinal cells. Journal of Agricultural and Food Chemistry 60 (35):8600–5. doi: 10.1021/jf301279k.
  • Matar, C., and J. Goulet. 1996. β-casomorphin 4 from milk fermented by a mutant of Lactobacillus helveticus. International Dairy Journal 6 (4):383–97. doi: 10.1016/0958-6946(95)00015-1.
  • McLachlan, C.N.S. 2001. β-Casein A1 ischemic heart mortality and other illnesses. Medical Hypotheses 56 (2):262–72. doi: 10.1054/mehy.2000.1265.
  • Meisel, H., and R.J. FitzGerald. 2000. Opioid peptides encrypted in intact milk protein sequences. British Journal of Nutrition 84 (S1):27–S31. doi: 10.1017/S000711450000221X.
  • Milan, A.M., A. Shrestha, H.J. Karlström, J.A. Martinsson, N.J. Nilsson, J. K. Perry, L. Day, M.P.G. Barnett, and D. Cameron-Smith. 2019. Comparison of the impact of bovine milk β-casein variants on igestive comfort in females self-reporting dairy intolerance: A randomized controlled trial. The American Journal of Clinical Nutrition 111:1–12.
  • Miyabe, R., Y. Takahashi, H. Matsufuji, J. Ogihara, K. Itou, Y. Kawai, T. Masuda, K. Suzuki, and M. Oda. 2015. Purification and partial characterization of an X-prolyl-dipeptidyl aminopeptidase from Lactobacillus gasseri ME-284. Food Science and Technology Research 21 (3):445–51. doi: 10.3136/fstr.21.445.
  • Morris, P.E., and R.J. FitzGerald. 2008. Whey proteins and peptides in human health. In Whey processing, functionality and health benefits, ed. C. Onwulata, 287–345. UK: Woodhead Publishing.
  • Murray, B.A., and R.J. FitzGerald. 2007. Angiotensin converting enzyme inhibitory peptides derived from food proteins: Biochemistry, bioactivity and production. Current Pharmaceutical Design 13 (8):773–91. doi: 10.2174/138161207780363068.
  • Nguyen, D.D., V.A. Solah, S.K. Johnson, J.W.A. Charrois, and F. Busetti. 2014. Isotope dilution liquid chromatography-tandem mass spectrometry for simultaneous identification and quantification of beta-casomorphin 5 and beta-casomorphin 7 in yoghurt. Food Chemistry 146:345–52. doi: 10.1016/j.foodchem.2013.09.057.
  • Nguyen, D.D., F. Busetti, S.K. Johnson, and V.A. Solah. 2015. Identification and quantification of native β-casomorphins in Australian milk by LC-MS/MS and LC-HRMS. Journal of Food Composition and Analysis 44:102–10. doi: 10.1016/j.jfca.2015.08.009.
  • Nguyen, D.D., F. Busetti, S.K. Johnson, and V.A. Solah. 2018. Degradation of beta-casomorphins and identification of degradation products during yoghurt processing using liquid chromatography coupled with high resolution mass spectrometry. Food Research International 106:98–104. doi: 10.1016/j.foodres.2017.12.035.
  • Nguyen, D. D., V. A. Solah, S. K. Johnson, H. A. Nguyen, T. L. D. Nguyen, T. L. H. Tran, T. K. Mai, and F. Busetti. 2019. Identification and quantification of beta-casomorphin peptides naturally yielded in raw milk by liquid chromatography-tandem mass spectrometry. Lwt - Lwt 111:465–9. doi: 10.1016/j.lwt.2019.05.074.
  • Obeid, R., A. Schadt, U. Dillmann, P. Kostopoulos, K. Fassbender, and W. Herrmann. 2009. Methylation status and neurodegenerative markers in Parkinson disease. Clinical Chemistry 55 (10):1852–60. doi: 10.1373/clinchem.2009.125021.
  • Osborne, S., W. Chen, R. Addepalli, M. Colgrave, T. Singh, C. Tran, and L. Day. 2014. In vitro transport and satiety of a beta-lactoglobulin dipeptide and beta-casomorphin-7 and its metabolites. Food and Function 5 (11):2706–18. doi: 10.1039/C4FO00164H.
  • Ozdemir, M., S. Kopuzlu, M. Topal, and O. C. Bilgin. 2018. Relationships between milk protein polymorphisms andproduction traits in cattle: A systematic review andmeta-analysis. Archives Animal Breeding 61 (2):197–206. doi: 10.5194/aab-61-197-2018.
  • Pal, S., K. Woodford, S. Kukuljan, and S. Ho. 2015. Milk intolerance, beta-casein and lactose. Nutrients 7 (9):7285–97. doi: 10.3390/nu7095339.
  • Panksepp, J. 1979. A neurochemical theory of autism. Trends in Neurosciences 2:174–7. doi: 10.1016/0166-2236(79)90071-7.
  • Parashar, A., and R.K. Saini. 2015. A1 milk and its controversy—a review. International Journal of Bioassay 4:4611–9.
  • Pasternak, G.W., and Y.X. Pan. 2013. Mu opioids and their receptors: Evolution of a concept. Pharmacological Reviews 65 (4):1257–317. doi: 10.1124/pr.112.007138.
  • Pellissier, L. P., J. Gandía, T. Laboute, J. A. J. Becker, and J. Le Merrer. 2018. μ opioid receptor, social behavior and autism spectrum disorders: Rewards matters. British Journal of Pharmacology 175 (14):2750–69. doi: 10.1111/bph.13808.
  • Pinto, M., S. Robine, and M.D. Appay. 1983. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line caco-2 in culture. Biology of Cell 47:323–30.
  • Poulsen, N.A., M. Glantz, A.K. Rosengaard, M. Paulsson, and L.B. Larsen. 2017. Comparison of milk protein composition and rennet coagulation properties in native Swedish dairy cow breeds and high-yielding Swedish red cows. Journal of Dairy Science 100 (11):8722–34. doi: 10.3168/jds.2017-12920.
  • Raies-Ul-Haq, M., R. Kapila, R. Sharma, V. Saliganti, and S. Kapila. 2014. Comparative evaluation of cow beta-casein variants (A1/A2) consumption on Th2-mediated inflammatory response in mouse gut. European Journal of Nutrition 53:1039–49. doi: 10.1007/s00394-013-0606-7.
  • Raies-Ul-Haq, M., R. Kapila, and V. Saliganti. 2014. Consumption of beta-casomorphins-7/5 induce inflammatory immune response in mice gut through Th2 pathway. Journal of Functional Foods 8:150–60. doi: 10.1016/j.jff.2014.03.018.
  • Raies-Ul-Haq, M., R. Kapila, and S. Kapila. 2015. Release of β-casomorphin-7/5 during simulated gastrointestinal digestion of milk β-casein variants from Indian crossbred cattle (Karan Fries). Food Chemistry 168:70–4. doi: 10.1016/j.foodchem.2014.07.024.
  • Reichelt, K.L., J. Ekrem, and H. Scott. 1990. Gluten, milk proteins and autism: Dietary intervention effects on behavior and peptide secretion. Journal of Applied Nutrition 42:1–11.
  • Reichelt, K.L., A.M. Knivsberg, M. Nødland, and G. Lind. 1994. Nature and consequence of hyperpeptiduria and bovine casomorphine found in autistic syndromes. Developmental Brain Dysfunction 7:71–85.
  • Reichelt, K.L., and A.M. Knivsberg. 2003. Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Nutritional Neuroscience 6 (1):19–28. doi: 10.1080/1028415021000042839.
  • Reichelt, K.L., D. Tveiten, A.M. Knivsberg, and G. Brønstad. 2012. Peptides’ role in autism with emphasis on exorphins. Microbial Ecology in Health and Disease 23:18958.
  • Ribeiro, J. A., A. M. Sebastião, and A. de Mendonça. 2002. Adenosine receptors in the nervous system: Pathophysiological implications. Progress in Neurobiology 68 (6):377–92. doi: 10.1016/S0301-0082(02)00155-7.
  • Sakurai, T., A. Yamada, N. Hashikura, T. Odamaki, and J.Z. Xiao. 2018. Degradation of food-derived opioid peptides by bifidobacteria. Beneficial Microbes 9 (4):675–82. doi: 10.3920/BM2017.0165.
  • Sambuy, Y., I. De Angelis, G. Ranaldi, M.L. Scarino, A. Stammati, and F. Zucco. 2005. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional Characteristics. Cell Biology and Toxicology 21 (1):1–26. doi: 10.1007/s10565-005-0085-6.
  • Samsam, M., R. Raheleh Ahangari, and S.A. Naser. 2014. Pathophysiology of autism spectrum disorders: Revisiting gastrointestinal involvement and immune imbalance. World Journal of Gastroenterology 20 (29):9942–51. doi: 10.3748/wjg.v20.i29.9942.
  • Saulo, C.R., S.E. Kennedy, Y.R. Smith, C.S. Stohler, and J.K. Zubieta. 2005. Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29:1264–80. doi: 10.1016/j.pnpbp.2005.08.011.
  • Sienkiewicz-Szlapka, E., B. Jarmolowska, S. Krawczuk, E. Kostyra, H. Kostyra, and K. Bielikowicz. 2009. Transport of bovine milk-derived opioid peptides across a Caco-2 monolayer. International Dairy Journal 19:252–7. doi: 10.1016/j.idairyj.2008.10.007.
  • Simões, E., A.C. Silva, K.D. Silveira, A.J. Ferreira, and M.M. Texeira. 2013. ACE2, angiotensin- (1–7) and MAS receptor axis in inflammation and fibrosis. British Journal of Pharmacology 169:477–92. doi: 10.1111/bph.12159.
  • Smith, J.C., A.P.L. Abdala, A. Borgmann, I.A. Rybak, and J.F.R. Paton. 2013. Brainstem respiratory networks: Building block and microcircuits. Trends in Neurosciences 36 (3):152–62. doi: 10.1016/j.tins.2012.11.004.
  • Sokolov, O.Y., N.A. Pryanikova, N.V. Kost, Y.A. Zolotarev, E.N. Ryukert, and A.A. Zozulya. 2005. Reactions between β-casomorphins-7 and 5-HT 2-serotonin receptors. Bulletin of Experimental Biology and Medicine 140 (5):582–4. doi: 10.1007/s10517-006-0030-6.
  • Sokolov, O.Y., N.V. Kost, Y.A. Zolotarev, E.N. Ryukert, and A.A. Zozulya. 2006. Influence of human β-casomorphin-7 on specific binding of 3H-spiperone to the 5-HT2-receptors of rat brain frontal cortex. Protein & Peptide Letters 13 (2):169–70. doi: 10.2174/092986606775101733.
  • Sokolov, O.Y., N.V. Kost, O. Andreeva, E. Korneeva, V. Meshavkin, Y. Tarakanova, A. Dadayan, Y. Zolotarev, S. Grachev, I. Mikheeva, et al. 2014. Autistic children display elevated urine levels of bovine casomorphin-7 immunoreactivity. Peptides 56:68–71. doi: 10.1016/j.peptides.2014.03.007.
  • Sparks, M.A., S.D. Crowley, S.B. Gurley, M. Mirotsou, and T.M. Coffman. 2014. Classical Renin-Angiotensin system in kidney physiology. Comprehensive Physiology 4 (3):1201–28. doi: 10.1002/cphy.c130040.
  • Sternini, C., S. Patierno, I.S. Selmer, and A. Kirchgessner. 2004. The opioid system in the gastrointestinal tract. Neurogastroenterology and Motility 12:3–6. doi: 10.1111/j.1743-3150.2004.00553.x.
  • Sumińiska-Zienmann, B., T. Gos, and Z. Jankowski. 2015. The role of respiratory failure caused by congenital central nervous system abnormalities and the effect of β-casomorphins in sudden infant death syndrome pathogenesis. Archives of Forensic Medicine and Criminology 65:99–111. doi: 10.5114/amsik.2015.53226.
  • Sun, Z., Z. Zhang, X. Wang, R. Cade, Z. Elmir, and M. Fregly. 2003. Relation of ß-casomorphin to apnea in sudden infant death syndrome. Peptides 24 (6):937–9. doi: 10.1016/S0196-9781(03)00156-6.
  • Tailford, K.A., C.L. Berry, A.C. Thomas, and J. H. Campbell. 2003. A casein variant in cow’s milk is atherogenic. Atherosclerosis 170 (1):13–9. doi: 10.1016/S0021-9150(03)00131-X.
  • Takahashi, A., I. M. Quadros, R. M. M. de Almeida, and K. A. Miczek. 2012. Behavioral and pharmacogenetics of aggressive behavior. Current Topics in Behavioral Neurosciences 12:73–138. doi: 10.1007/7854_2011_191.
  • Tester, D. J., L.C.H. Wong, P. Chanana, B. Gray, A. Jaye, J.M. Evans, M. Evans, P. Fleming, I. Jeffrey, M. a Cohen, et al. 2018. Exome-wide rare variant analyses in sudden infant death syndrome. The Journal of Pediatrics 203:423–8. doi: 10.1016/j.jpeds.2018.08.011.
  • Threadgill, D.W., and J.E. Womack. 1990. Genomic analysis of the major bovine milk proteins genes. Nucleic Acids Research 18 (23):6935–42. doi: 10.1093/nar/18.23.6935.
  • Trivedi, M.S., J.S. Shah, S. Al-Mughairy, N.W. Hodgson, B. Simms, G.A. Trooskens, W. Van Criekinge, and R.C. Deth. 2014. Food-derived opioid peptides inhibit cysteine uptake with redox and epigenetic consequences. The Journal of Nutritional Biochemistry 25 (10):1011–8. doi: 10.1016/j.jnutbio.2014.05.004.
  • Trivedi, M.S., N.W. Hodgson, S.J. Walker, G. Trooskens, V. Nair, and R.C. Deth. 2015. Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells. Nutrition & Metabolism 12:54. doi: 10.1186/s12986-015-0050-1.
  • Trivedi, M., Y. Zhang, M. Lopez-Toledano, A. Clarke, and R. Deth. 2016. Differential Neurogenic effects of casein-derived opioid peptides on neuronal stem cells: Implication for redox based epigenetic changes. The Journal of Nutritional Biochemistry 37:39–46. doi: 10.1016/j.jnutbio.2015.10.012.
  • Trompette, A., J. Claustre, F. Caillon, G. Jourdan, J. A. Chayvialle, and P. Plaisancié. 2003. Milk bioactive peptides and β-casomorphins induce mucus release in rat jejunum. The Journal of Nutrition 133 (11):3499–503. doi: 10.1093/jn/133.11.3499.
  • Tzvetkova, I., M. Dalgalarrondo, S. Danova, I. Iliev, I. Ivanova, J.-M. Chobert, and T. Haertlé. 2007. Hydrolysis of major dairy proteins by lactic acid bacteria from Bulgarian yogurts. Journal of Food Biochemistry 31 (5):680–702. doi: 10.1111/j.1745-4514.2007.00137.x.
  • Vij, R., S. Reddi, S. Kapila, and R. Kapila. 2016. Transepithelial transport of milk derived bioactive peptide VLPVPQK. Food Chemistry 190:681–8. doi: 10.1016/j.foodchem.2015.05.121.
  • Vuong, C., S. H. M. Van Uum, L. E. O'Dell, K. Lutfy, and T. C. Friedman. 2010. The effects of opioids and opioid analogs on animal and human endocrine system. Endocrine Reviews 31 (1):98–132. doi: 10.1210/er.2009-0009.
  • Wasilewska, J., E. Sienkiewicz-Szłapka, E. Kuźbida, B. Jarmołowska, M. Kaczmarski, and E. Kostyra. 2011. The exogenous opioid peptides and DPPIV serum activity in infants with apnea expressed as apparent life threatening events (ALTE). Neuropeptides 45 (3):189–95. doi: 10.1016/j.npep.2011.01.005.
  • Webb, K.E. 1990. Intestinal absorption of protein hydrolysis products: A review. Journal of Animal Science 68 (9):3011–22. doi: 10.2527/1990.6893011x.
  • Woodford, K.B. 2006. A critique of truswell’s A2 milk review. European Journal of Clinical Nutrition 60 (3):437–9. doi: 10.1038/sj.ejcn.1602322.
  • Yin, H., J.F. Miao, and Y. Zhang. 2010. Protective effect of beta-casomorphin-7 on type 1 diabetes rats induced with streptozotocin. Peptides 31 (9):1725–9. doi: 10.1016/j.peptides.2010.05.016.
  • Yin, H., J.F. Miao, C. Ma, G. Sun, and Y. Zhang. 2012. β-Casomorphin-7 cause decreasing in oxidative stress and inhibiting NF-κB-iNOS-NO signal pathway in pancreas of diabetes rat. Journal of Food Science 77 (2):C278–C282. doi: 10.1111/j.1750-3841.2011.02577.x.
  • Zhang, W., J. Miao, C. Ma, D. Han, and Y. Zhang. 2012. β-casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells. Peptides 36 (2):186–19. doi: 10.1016/j.peptides.2012.05.022.
  • Zhang, W., J. Miao, S. Wang, and Y. Zhang. 2013. The protective effects of β-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro. PLoS ONE 8 (5):e63472. doi: 10.1371/journal.pone.0063472.
  • Zhang, W., S. Song, F. Liu, Y. Liu, and Y. Zhang. 2015. Beta-casomorphin-7 prevents epithelial-mesenchymal transdifferentiation of NRK-52E cells at high glucose level: Involvement of AngII-TGF-β1 pathway. Peptides 70:37–44. doi: 10.1016/j.peptides.2015.04.002.
  • Zhu, L., J. Li, D. Wu, and B. Li. 2018. The protective effect of beta-casomorphin-7 via promoting foxo1 activity and nuclear translocation in human lens epithelial cells. Cutaneous and Ocular Toxicology 37 (3):267–74. doi: 10.1080/15569527.2018.1445095.
  • Zoghbi, S., A. Trompette, J. Claustre, M. E. Homsi, J. Garzon, G. Jourdan, J.Y. Scoazec, and P. Plaisancie. 2006. Beta-casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a mu-opioid pathway. American Journal of Physiology-Gastrointestinal and Liver Physiology 290 (6):G1105–1113. doi: 10.1152/ajpgi.00455.2005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.